CN109574946B - 二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途 - Google Patents

二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途 Download PDF

Info

Publication number
CN109574946B
CN109574946B CN201811512958.3A CN201811512958A CN109574946B CN 109574946 B CN109574946 B CN 109574946B CN 201811512958 A CN201811512958 A CN 201811512958A CN 109574946 B CN109574946 B CN 109574946B
Authority
CN
China
Prior art keywords
amine
diphenylamine
oxazoline
solvent
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811512958.3A
Other languages
English (en)
Other versions
CN109574946A (zh
Inventor
夏远志
陈建辉
刘红梅
况锦强
陈欣娅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou University
Original Assignee
Wenzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou University filed Critical Wenzhou University
Priority to CN201811512958.3A priority Critical patent/CN109574946B/zh
Publication of CN109574946A publication Critical patent/CN109574946A/zh
Application granted granted Critical
Publication of CN109574946B publication Critical patent/CN109574946B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/12—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals containing only hydrogen and carbon atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • B01J31/1815—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine
    • B01J31/182—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine comprising aliphatic or saturated rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/20—Preparation of ethers by reactions not forming ether-oxygen bonds by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/02—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation
    • C07C5/03—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation of non-aromatic carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/03—Sideramines; The corresponding desferri compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/643—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
    • B01J2531/0244—Pincer-type complexes, i.e. consisting of a tridentate skeleton bound to a metal, e.g. by one to three metal-carbon sigma-bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/20—Complexes comprising metals of Group II (IIA or IIB) as the central metal
    • B01J2531/26—Zinc
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
    • B01J2531/72—Manganese
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/842—Iron
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/845—Cobalt
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • C07C2531/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • C07C2531/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)

Abstract

本发明提供的二苯胺‑胺‑噁唑啉配体，为式(1)所述的化合物或者为式(1)所述化合物的对映体或消旋体，其中，R1和R2分别独立为C1～C10的烃基、苄基、苯基或取代的苯基、杂芳基中的一种；R3为H或甲基。本发明同时公开了合成方法及其金属配合物和用途，以提供能够通过简单的合成线路实现高合成产率的催化剂，并确保其对烯烃和酮的不对称氢化和氢转移反应中具有非常高的催化活性。

Description

二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途
技术领域
本发明涉及催化剂技术领域，尤其涉及二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途。
背景技术
过渡金属催化的不对称合成反应是制备手性化合物最为高效的方式之一，也是工业和学术界共同关注的热门领域。自从化学家们发现可以通过手性配体的结合来调节过渡金属在不对称催化反应中的活性和选择性之后，手性配体的设计就成为了过渡金属催化不对称合成领域的核心内容之一。至今已有数以千计的手性配体被发展出来应用于不对称合成反应，其中也涌现了一些具有广泛催化活性的优势手性配体[(a)Q.Zhou,PrivilegedChiralLigandsandCatalysts,Wiley-VCH,Weinheim,2011；b)T.P.Yoon,E.N.Jacobsen,Science2003,299,1691；c)A.faltz,W.J.DruryIII,PNAS2004,101,5723.]。手性噁唑啉可以由自然界常见的氨基酸来制备，是一类常见的手性配体砌块，如优势手性配体PyBox、BOX、PHOX等，可以和很多金属形成络合物催化许多类型的反应[(a)D.Rechavi,M.Lemaire,Chem.Rev.2002,102,346；(b)G.Desimoni,G.Faita,P.Quadrelli,Chem.Rev.2003,103,3119.]。因此，基于噁唑啉砌块构建不同的手性配体骨架引起了化学工作者的广泛兴趣，也由此实现了一些列高效的不对称催化转化，推动了不对称催化领域的发展[(a)S.Zhu,X.Song,Y.Li,Y.Cai,Q.Zhou,J.Am.Chem.Soc.2010,132,16374；(b)Y.Zhang,F.Wang,W.Zhang,J.Org.Chem.2007,72,9208；(c)B.Cheng,W.Liu,Z.Lu,J.Am.Chem.Soc.2018,140,501；(d)J.Guo,B.Cheng,X.Shen,Z.Lu,J.Am.Chem.Soc.2017,139,15316.]。
烯烃、酮等不饱和有机化合物的不对称氢化和氢转移等还原反应是高效的合成光学活性分子的手段，具有原子经济性高、操作简单、清洁绿色等优点，在化工工业大生产中有着重要的应用。现有的催化体系主要是基于铑、钌、铱、钯等铂族贵金属和手性膦配体的组合。铂族金属在地壳中储量较少(总计可开采储量为仅7.1万吨)，属于战略性资源；同时手性膦配体的合成效率是一个难题。
因此，开发一种新的二苯胺-胺-噁唑啉配体，实现铁和钴等地球丰产过渡金属在不对称催化领域的广发应用，并进一步研究其高效合成的线路，不但具有迫切的研究价值，也具有良好的经济效益和工业应用潜力，这正是本发明得以完成的动力所在和基础。
发明内容
为了克服上述所指出的现有技术的缺陷，本发明人对此进行了深入研究，在付出了大量创造性劳动后，从而完成了本发明。
具体而言，本发明所要解决的技术问题是：提供二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途，以提供能够通过简单的合成线路实现高合成产率的催化剂，并确保其对烯烃和酮的不对称氢化和氢转移反应中具有非常高的催化活性。
为解决上述技术问题，本发明的技术方案是：
第一方面，本发明提供了二苯胺-胺-噁唑啉配体，其为式(1)所述的化合物
Figure GDA0003785642980000021
或者为式(1)所述化合物的对映体或消旋体，其中，
R1和R2分别独立为C1～C10的烃基、苄基、苯基或取代的苯基、杂芳基；R3为H或甲基。
其中，所述的烃基为甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、正戊基、环戊基、正己基、环己基。
本发明中，作为一种优选的技术方案，R1优选为甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、苯基或苄基中的一种。
本发明中，作为一种优选的技术方案，R2优选为取代的苯基和环己基。其中，取代的苯基中取代基为C1～C6的烃基、烃氧基以及卤素，取代基数量为1-5。
第二方面，本发明提供了上述二苯胺-胺-噁唑啉配体的合成方法，包括如下步骤：
第一步：溶剂中，邻溴苯甲醛和胺在对甲苯磺酸(p-TsOH)的催化下缩合得到相应的亚胺，随后经氢化铝锂(LiAlH4)还原得到中间体—N-取代的邻溴苄胺(A)；
第二步：溶剂中，邻氨基苯腈和手性胺基醇在Zn(OTf)2的催化下缩合得到中间体—邻位噁唑啉取代的苯胺(B)；
第三步：惰性气氛下，二氧六环溶剂中，邻溴苄胺(A)和苯胺(B)在醋酸钯的催化下偶联得到产物二苯胺-胺-噁唑啉配体(1)。
本发明中，作为作为一种优选的技术方案，第一步和第二步中的溶剂为甲苯溶剂。
本发明中，作为作为一种优选的技术方案，第三步中的溶剂为二氧六环溶剂。
其合成路线如下：
Figure GDA0003785642980000041
第三方面，本发明提供了二苯胺-胺-噁唑啉金属配合物，该配合物是由化合物1与元素周期表的过渡族的过渡金属形成，且具有如式(2)所述的通式
Figure GDA0003785642980000042
其中，M为过渡金属Fe、Co、Ni、Cu、Ag、Au、Ru、Rh、Pd、Os、Ir中的一种；
X选自卤化物(F、Cl、Br、I)、拟卤化物(氰化物、氰酸、盐、异氰酸盐)、羧酸、磺酸、膦酸的阴离子(碳酸根、甲酸根、乙酸根、丙酸根、甲基磺酸根、三氯甲基磺酸根、苯基磺酸根、甲苯磺酸根)中的任意一种；
E为H或甲基；
n1为X的个数，为0、1、2、3；
n2为E的个数，为0或1。
R1和R2分别独立为C1～C10的烃基、苄基、苯基或取代的苯基、杂芳基；R3为H或甲基。
其中，所述的烃基为甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、正戊基、环戊基、正己基、环己基。
本发明中，作为一种优选的技术方案，R1优选为甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、苯基或苄基中的一种。
本发明中，作为一种优选的技术方案，R2优选为取代的苯基和环己基。其中，取代的苯基中取代基为C1～C6的烃基、烃氧基以及卤素，取代基数量为1-5。
第四方面，本发明提供了二苯胺-胺-噁唑啉配体以及二苯胺-胺-噁唑啉金属配合物的用途，是指利用催化量的至少一种二苯胺-胺-噁唑啉配体或二苯胺-胺-噁唑啉金属配合物作为催化剂通过催化反应制备光学选择性有机化合物。例如可以以二苯胺-胺-噁唑啉金属配合物催化三取代烯烃的不对称氢化反应及酮的不对称氢转移反应。
采用了上述技术方案后，本发明的有益效果是：
本发明提供了一种新型二苯胺-胺-噁唑啉配体，二苯胺-胺-噁唑啉配体可以独立用于制备手性或非手性有机化合物，也可以与过渡金属Fe、Co、Ni、Cu、Ag、Au、Ru、Rh、Pd、Os、Ir形成稳定的金属配合物，该金属配合物能够应用于不对称催化反应，特别是对烯烃和酮的不对称氢化和氢转移反应中具有非常高的催化活性。本发明还提供了高效的合成路线，两步总产率均在80％以上。
本发明还提供了化合物1应用于金属催化不对称反应的用途，通过与金属预配位形成的金属催化剂或与金属盐现场生成金属催化剂，化合物1可以用于制备手性或非手性有机化合物。可根据本发明制备的手性或非手性有机化合物是活性物质或用于制备该物质的中间物，特别是在香料和增香剂、药物制剂、农用化学品的生产方面。
具体实施方式
下面结合具体的实施例对本发明进一步说明。但这些例举性实施方式的用途和目的仅用来例举本发明，并非对本发明的实际保护范围构成任何形式的任何限定，更非将本发明的保护范围局限于此。
二苯胺-胺-噁唑啉配体，其为式(1)所述的化合物
Figure GDA0003785642980000061
或者为式(1)所述化合物的对映体或消旋体，其中，R1和R2分别独立为C1～C10的烃基、苄基、苯基或取代的苯基、杂芳基；R3为H或甲基。
上述二苯胺-胺-噁唑啉配体的合成方法，包括如下步骤：
第一步：室温，反应瓶内依次加入邻溴苯甲醛(20mmol)、甲苯(30mL)、胺(22mmol)和甲苯磺酸一水合物(1mmol)，升温至回流反应12小时；随后冷却至室温，硅藻土抽滤，滤液减压旋转蒸发除去溶剂得到相应的亚胺(黄色胶状物)。
另取一三口反应瓶，依次加入氢化铝锂(22mmol)、四氢呋喃(20mL)，0℃、氮气氛下滴加亚胺/四氢呋喃(20mL)溶液，滴加结束后升温至回流反应12小时；
随后冷却至室温，缓慢滴加饱和氯化铵溶液猝灭反应，加入乙酸乙酯(20mL)和饱和食盐水(10mL)，分液，水相再用乙酸乙酯萃取两次，合并有机相，无水硫酸钠干燥后减压旋转蒸发除去溶剂得到中间体A，反应方程式如下：
Figure GDA0003785642980000062
中间体A的检测结果如下：
Figure GDA0003785642980000063
无色油状液体，产率为92％。1H NMR:(500.1MHz,CDCl3)δ7.57(d,J＝8.0Hz,1H),7.36(d,J＝7.6Hz,1H),7.28-7.22(m,1H),7.17-7.10(m,1H),6.99(d,J＝7.6Hz,1H),6.88-6.81(m,2H),4.20(s,2H),2.26(s,6H).
Figure GDA0003785642980000071
1H NMR:(500.1MHz,CDCl3)δ7.58(d,J＝8.0Hz,1H),7.42(d,J＝7.6Hz,1H),7.32-7.25(m,1H),7.19-7.04(m,4H),4.12(s,2H),3.43(br,1H),3.35-3.23(m,2H),1.21(d,J＝7.0Hz,12H)；
第二步：室温，反应瓶内依次加入邻氨基苯腈(10mmol)、甲苯(10mL)、手性胺基醇(11mmol)和Zn(OTf)2(1mmol)，升温至回流反应24小时，冷却至室温，减压浓缩后柱层析分离得到中间体B，反应方程式为：
Figure GDA0003785642980000072
第三步：室温，惰性气氛下，反应瓶内依次加入中间体A(11mmol)、二氧六环(20mL)、中间体B(10mmol)、醋酸钯(0.5mmol)、双(2-二苯基磷苯基)醚(0.6mmol)和叔丁醇钠(15mmol)，升温至回流反应24小时，冷却至室温，硅胶短柱抽滤，滤液减压浓缩后经柱层析分离得到产物二苯胺-胺-噁唑啉配体(1)。
Figure GDA0003785642980000073
采用如上的制备方法，根据原料的不同，选择R1、R2的种类，分别可以得到如下的二苯胺-胺-噁唑啉配体(1)：
实施例1
采用如上的制备方法，选择R1、R2的种类，得到如下的二苯胺-胺-噁唑啉配体(1a)，为白色固体，产率为88％。
检测结果如下：
Figure GDA0003785642980000081
1H NMR:(500.1MHz,CDCl3)δ10.39(br,1H),7.77(dd,J＝8.0,1.6Hz,1H),7.47-7.38(m,2H),7.32-7.25(m,1H),7.24-7.07(m,7H),7.02(d,J＝8.4Hz,1H),6.93(d,J＝7.6Hz,2H),6.81-6.75(m,1H),6.75-6.69(m,1H),4.59-4.49(m,1H),4.28(dd,J＝9.0,8.6Hz,1H),4.12-3.99(m,3H),3.01(dd,J＝13.7,5.8Hz,1H),2.70(dd,J＝13.7,8.2Hz,1H),2.18(s,6H)；HRMSCalcdfor[C31H31N3O+H]+:462.2540；found:462.2544.
实施例2
采用如上的制备方法，选择R1、R2的种类，得到如下的二苯胺-胺-噁唑啉配体(1b)，为白色固体，产率为87％。
检测结果如下：
Figure GDA0003785642980000082
1H NMR:(399.9MHz,CDCl3)δ10.43(br,1H),7.78(dd,J＝8.0,1.6Hz,1H),7.47(d,J＝7.6Hz,1H),7.44(d,J＝8.0Hz,1H),7.31-7.25(m,1H),7.24-7.17(m,1H),7.16-7.09(m,1H),7.01(d,J＝8.4Hz,1H),6.94(d,J＝7.6Hz,2H),6.83-6.75(m,1H),6.75-6.69(),4.38-4.28(m,1H),4.15(1,J＝13.6Hz,2H),4.10-3.97(m,2H),3.35(br,1H),2.18(s,6H),1.78-1.65(m,1H),0.92(d,J＝6.8Hz,3H),0.85(d,J＝6.8Hz,3H)；13CNMR:(125.8MHz,CDCl3)δ13CNMR:(125.8MHz,CDCl3)delta163.7,146.8,146.0,139.6,134.9,131.9,130.0,129.9,129.8,128.6,128.0,124.3,124.2,122.0,116.6,113.0,110.2,72.9,68.8,49.0,33.0,18.9,18.5,18.3.HRMS Calcdfor[C27H31N3O+H]+:414.2545；found:414.2550.
实施例3
采用如上的制备方法，选择R1、R2的种类，得到如下的二苯胺-胺-噁唑啉配体(1c)，为白色固体，产率为88％。
检测结果如下：
Figure GDA0003785642980000091
1H NMR:(399.9MHz,CDCl3)δ10.41(s,1H),7.79(dd,J＝7.8,1.6Hz,1H),7.57(dd,J＝7.8,1.2Hz,1H),7.41(d,J＝7.8Hz,1H),7.36-7.27(m,1H),7.24-7.16(m,2H),7.08-6.99(m,3H),6.94(d,J＝8.4Hz,1H),6.75-6.68(m,1H),4.26(dd,J＝9.6,8.4Hz,1H),4.13(dd,J＝8.4,8.0Hz,1H),4.10-4.00(m,3H),3.31(br,1H),3.26-3.13(m,2H),1.11(d,J＝7.0Hz,6H),1.07(d,J＝7.0Hz,6H),0.85(s,9H)；13CNMR:(125.8MHz,CDCl3)δ163.7,147.2,143.1,142.8,139.4,135.7,132.0,129.9,129.8,128.1,125.3,125.0,123.8,123.4,116.5,112.7,109.9,76.3,67.0,52.3,33.8,27.6,25.9,24.2,24.1；HRMSCalcdfor[C32H41N3O+H]+:484.3328；found:484.3329.
实施例4
采用如上的制备方法，选择R1、R2的种类，得到如下的二苯胺-胺-噁唑啉配体(1d)，为白色固体，产率为89％。
检测结果如下：
Figure GDA0003785642980000101
1H NMR:(399.9MHz,CDCl3)δ10.45(br,1H),7.78(dd,J＝8.0,1.6Hz,1H),7.46(d,J＝8.0Hz,1H),7.39(dd,J＝7.6,1.2Hz,1H),7.32-7.25(m,1H),7.25-7.18(m,1H),7.12-7.06(m,1H),7.04(d,J＝8.4Hz,1H),6.94(d,J＝7.6Hz,2H),6.82-6.76(m,1H),6.76-6.69(m,1H),4.14(s,2H),4.00(s,2H),3.40(br,1H),2.20(s,6H),1.27(s,6H).HRMSCalcdfor[C26H29N3O+H]+:400.2383；found:400.2388。
实施例5
二苯胺-胺-噁唑啉-铁配合物的合成
Figure GDA0003785642980000102
室温，氮气氛下，反应瓶内依次加入实施例1制备得到的二苯胺-胺-噁唑啉配体1a(1mmol)，干燥四氢呋喃(THF)(5mL)和氯化亚铁(FeCl2)(0.95mmol)，反应液逐渐变棕绿色悬浊液，搅拌反应5小时后抽滤，滤饼用乙醚洗涤三次(每次5mL)，收集滤饼，油泵抽干得到棕绿色粉末状固体(2a)，产率为88％。
检测结果如下：
Figure GDA0003785642980000103
Anal.CalcdforC31H31Cl2FeN3O:C,63.29；H,5.31；N,7.14；FoundC,63.00；H,5.36；N,6.99.
实施例6
二苯胺-胺-噁唑啉-钴配合物的合成
Figure GDA0003785642980000111
室温，氮气氛下，反应瓶内依次加入实施例1制备得到的二苯胺-胺-噁唑啉配体1a(1mmol)，干燥四氢呋喃(THF)(5mL)和氯化钴(CoCl2)(0.95mmol)，反应液逐渐变绿色悬浊液，搅拌反应5小时后抽滤，滤饼用乙醚洗涤三次(每次5mL)，收集滤饼，油泵抽干得到绿色粉末状固体(2b)，产率为96％。
检测结果如下：
Figure GDA0003785642980000112
Anal.CalcdforC31H31Cl2CoN3O:C,62.95；H,5.28；N,7.10；FoundC,62.88；H,5.11；N,6.92.
实施例7
二苯胺-胺-噁唑啉-锰配合物的合成
Figure GDA0003785642980000113
室温，氮气氛下，反应瓶内依次加入实施例1制备得到的二苯胺-胺-噁唑啉配体1a(1mmol)，干燥四氢呋喃(THF)(5mL)和氯化锰(MnCl2)(0.95mmol)，反应液逐渐变浅黄色悬浊液，搅拌反应5小时后抽滤，滤饼用乙醚洗涤三次(每次5mL)，收集滤饼，油泵抽干得到黄白色粉末状固体(2c)，产率为94％。
检测结果如下：
Figure GDA0003785642980000121
Anal.CalcdforC31H31Cl2MnN3O:C,63.38；H,5.32；N,7.15；FoundC,62.99；H,5.01；N,6.96.
实施例8
二苯胺-胺-噁唑啉-锌配合物的合成
Figure GDA0003785642980000122
室温，氮气氛下，反应瓶内依次加入实施例1制备得到的二苯胺-胺-噁唑啉配体1a(1mmol)，干燥四氢呋喃(THF)(5mL)和氯化锌(ZnCl2)(0.95mmol)，反应液逐渐变白色悬浊液，搅拌反应5小时后抽滤，滤饼用乙醚洗涤三次(每次5mL)，收集滤饼，油泵抽干得到白色粉末状固体(2d)，产率为85％。
检测结果如下：
Figure GDA0003785642980000131
Anal.CalcdforC31H31Cl2ZnN3O:C,62.28；H,5.23；N,7.03；FoundC,62.13；H,5.20；N,6.99.
实施例9
催化三取代烯烃的不对称氢化反应
Figure GDA0003785642980000132
室温，氮气氛下，在一干燥的反应试管中加入(手性)二苯胺-胺-噁唑啉-CoCl2配合物(2b)(0.005mmol)，烯烃(0.5mmol)，抽真空后反应管连接一个氢气球，随后注射加入干燥的甲苯(1mL)和三乙基硼氢化钠溶液(0.010mmol)，室温下搅拌1小时后柱层析分离得到氢化产物。
检测结果如下：
Figure GDA0003785642980000133
无色油状液体，>99％产率，[α]20 D＝25.8(c0.86,CHCl3)，95.2％ee；1H NMR:(400.1MHz,CDCl3)δ7.09(d,J＝8.4Hz,2H),6.83(d,J＝8.4Hz,2H),3.78(s,3H),2.60-2.48(m,1H),1.61-1.49(m,2H),1.21(d,J＝7.0Hz,3H),0.81(t,J＝7.4Hz,3H).
Figure GDA0003785642980000134
无色油状液体，>99％产率，[α]20 D＝22.2(c0.89,CHCl3)，94.6％ee；1H NMR:(400.1MHz,CDCl3)δ7.14-7.03(m,4H),2.65-2.49(m,1H),2.31(s,3H),1.64-1.52(m,2H),1.22(d,J＝6.8Hz,3H),0.82(t,J＝7.2Hz,3H).
Figure GDA0003785642980000141
无色油状液体，>99％产率，[α]20 D＝23.2(c0.96,CHCl3)，93.2％ee；1H NMR:(400.1MHz,CDCl3)δ7.32-7.23(m,2H),7.22-7.13(m,3H),2.72-2.59(m,1H),1.62-1.48(m,2H),1.34-1.08(m,7H),0.85(t,J＝6.8Hz,3H).
Figure GDA0003785642980000142
无色油状液体，>99％产率，[α]20 D＝19.4(c1.01,CHCl3)；95.0％ee；1H NMR:(400.1MHz,CDCl3)δ7.32-7.22(m,2H),7.22-7.11(m,3H),2.84-2.70(m,1H),1.58-1.31(m,3H),1.20(d,J＝7.0Hz,3H),0.87(d,J＝6.0Hz,3H),0.84(d,J＝6.0Hz,3H).
实施例10
氯化钴催化三取代烯烃的氢化反应(对比实施例)
Figure GDA0003785642980000143
室温，氮气氛下，在一干燥的反应试管中加入CoCl(0.005mmol)，烯烃(0.5mmol)，抽真空后反应管连接一个氢气球，随后注射加入干燥的甲苯(1mL)和三乙基硼氢化钠溶液(0.010mmol)，室温下搅拌1小时后气质联用检测未发现氢化产物。
实施例11
催化酮的不对称氢转移反应
Figure GDA0003785642980000151
室温，氮气氛下，在一干燥的反应试管中加入(手性)二苯胺-胺-噁唑啉-CoCl2配合物(2b)(0.005mmol)，酮(0.5mmol)，异丙醇(1mL)和叔丁醇钠(0.025mmol)，然后在40℃下反应12小时后柱层析分离得到氢转移产物。
检测结果如下：
Figure GDA0003785642980000152
油状液体，98％产率，[α]20 D＝+58.5(c0.99,CHCl3)；97.1％ee；1H NMR(CDCl3,400MHz):δ7.27-7.40(m,4H),7.24-7.30(m,1H),4.84-4.93(m,1H),1.93(br,1H),1.49(d,J＝6.2Hz,3H).
Figure GDA0003785642980000153
油状液体，92％产率，[α]20 D＝+55.4(c1.01,CHCl3)；97.7％ee；1H NMR(CDCl3,400MHz):δ7.27(d,J＝7.8Hz,2H),7.16(d,J＝7.8Hz,2H),4.82-4.92(m,1H),2.34(s,3H),1.79(br,1H),1.48(d,J＝6.4Hz,3H).
Figure GDA0003785642980000154
油状液体，94％产率，[α]20 D＝+17.5(c1.1,CHCl3)；97.5％ee；1H NMR(CDCl3,400MHz):δ7.30(d,J＝7.8Hz,2H),6.88(d,J＝7.8Hz,2H),4.82-4.91(m,1H),3.81(s,3H),1.73(br,1H),1.48(d,J＝6.2Hz,3H).
Figure GDA0003785642980000155
油状液体，95％产率，[α]20 D＝+35.5(c1.01,CHCl3)；96.6％ee；1H NMR(CDCl3,400MHz):δ7.27(d,J＝7.6Hz,2H),7.12(d,J＝7.0Hz,2H),4.80-4.90(m,1H),2.46(d,J＝6.8Hz,2H),1.78-1.97(m,2H),1.44-1.53(m,3H),0.85-0.96(m,6H).
Figure GDA0003785642980000161
油状液体，89％产率，[α]20 D＝+44.8(c0.88,CHCl3)；96.0％ee；1H NMR(CDCl3,400MHz):δ7.30-7.41(m,2H),7.03(t,J＝8.6Hz,2H),4.81-4.92(m,1H),1.95(br,1H),1.47(d,J＝6.4Hz,3H).
Figure GDA0003785642980000162
油状液体，97％产率，[α]20 D＝+44.2(c0.93,CHCl3)；96.1％ee；1H NMR(CDCl3,400MHz):δ7.23-7.34(m,4H),4.79-4.87(m,1H),2.30(br,1H),1.44(d,J＝6.4Hz,3H).
Figure GDA0003785642980000163
油状液体，97％产率，[α]20 D＝+35.7(c0.98,CHCl3)；96.0％ee；1H NMR(CDCl3,400MHz):δ7.47(d,J＝8.0Hz,2H),7.25(d,J＝8.0Hz,2H),4.82-4.92(m,1H),1.84(br,1H),1.47(d,J＝6.4Hz,3H).
实施例12
氯化钴催化酮的氢转移反应(对比实施例)
Figure GDA0003785642980000164
室温，氮气氛下，在一干燥的反应试管中加入CoCl2(0.005mmol)，酮(0.5mmol)，异丙醇(1mL)和叔丁醇钠(0.025mmol)，然后在40℃下反应12小时气质联用检测未发现产物。
由以上实施例可知，采用本发明制备得到的二苯胺-胺-噁唑啉-CoCl2配合物能够有效催化烯烃或酮的不对称氢化和氢转移反应。
当理解，这些实施例的用途仅用于说明本发明而非意欲限制本发明的保护范围。此外，也应理解，在阅读了本发明的技术内容之后，本领域技术人员可以对本发明作各种改动、修改和/或变型，所有的这些等价形式同样落于本申请所附权利要求书所限定的保护范围之内。

Claims (6)

1.二苯胺-胺-噁唑啉配体，其特征在于：为式(1)所述的化合物
Figure FDA0003822719440000011
其中，
R1为苄基；R2为2，6-二甲基苯基；R3为H。
2.合成如权利要求1所述二苯胺-胺-噁唑啉配体的方法，其特征在于：包括如下步骤：
第一步：溶剂中，邻溴苯甲醛和胺在对甲苯磺酸的催化下缩合得到相应的亚胺，随后经氢化铝锂还原得到中间体N-取代的邻溴苄胺(A)
Figure FDA0003822719440000012
第二步：溶剂中，邻氨基苯腈和手性胺基醇在Zn(OTf)2的催化下缩合得到中间体邻位噁唑啉取代的苯胺(B)
Figure FDA0003822719440000013
第三步：惰性气氛下，溶剂中，中间体—N-取代的邻溴苄胺(A)和邻位噁唑啉取代的苯胺(B)在醋酸钯的催化下偶联得到产物二苯胺-胺-噁唑啉配体(1)；
其中，
R1为苄基；R2为2，6-二甲基苯基；R3为H。
3.如权利要求2所述的合成方法，其特征在于：第一步和第二步中的溶剂为甲苯溶剂。
4.如权利要求2所述的合成方法，其特征在于：第三步中的溶剂为二氧六环溶剂。
5.二苯胺-胺-噁唑啉金属配合物，其特征在于：该配合物是权利要求1所述的化合物与元素周期表的过渡族的过渡金属形成，且具有如式(2)所述的通式
Figure FDA0003822719440000021
其中，M为过渡金属Co；
X为Cl；
E为H；
n1为2；
n2为1；
R1为苄基；R2为2，6-二甲基苯基；R3为H。
6.如权利要求5所述二苯胺-胺-噁唑啉金属配合物的用途，其特征在于：以所述二苯胺-胺-噁唑啉金属配合物催化三取代烯烃的不对称氢化反应及酮的不对称氢转移反应。
CN201811512958.3A 2018-12-11 2018-12-11 二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途 Active CN109574946B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811512958.3A CN109574946B (zh) 2018-12-11 2018-12-11 二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811512958.3A CN109574946B (zh) 2018-12-11 2018-12-11 二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途

Publications (2)

Publication Number Publication Date
CN109574946A CN109574946A (zh) 2019-04-05
CN109574946B true CN109574946B (zh) 2022-10-04

Family

ID=65929641

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811512958.3A Active CN109574946B (zh) 2018-12-11 2018-12-11 二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途

Country Status (1)

Country Link
CN (1) CN109574946B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111974457B (zh) * 2020-08-31 2021-05-28 江南大学 一种用于合成取代酮类化合物的催化剂及制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447725A (zh) * 2014-10-22 2015-03-25 浙江大学 一种手性含亚胺吡啶噁唑啉的化合物及其制备方法
CN104478919A (zh) * 2014-11-18 2015-04-01 浙江大学 一种合成手性硅烷化合物的方法
CN105461508A (zh) * 2015-11-19 2016-04-06 浙江大学 一种合成手性1,1-二芳基乙烷类化合物的方法
CN105693647A (zh) * 2016-01-11 2016-06-22 浙江大学 一种手性含亚胺噁唑啉胺类的化合物及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447725A (zh) * 2014-10-22 2015-03-25 浙江大学 一种手性含亚胺吡啶噁唑啉的化合物及其制备方法
CN104478919A (zh) * 2014-11-18 2015-04-01 浙江大学 一种合成手性硅烷化合物的方法
CN105461508A (zh) * 2015-11-19 2016-04-06 浙江大学 一种合成手性1,1-二芳基乙烷类化合物的方法
CN105693647A (zh) * 2016-01-11 2016-06-22 浙江大学 一种手性含亚胺噁唑啉胺类的化合物及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
基于配体设计的铁、钴催化酮/烯烃不对称氢官能团化反应研究;陈旭;《浙江大学博士学位论文》;20180515;第1-69页 *

Also Published As

Publication number Publication date
CN109574946A (zh) 2019-04-05

Similar Documents

Publication Publication Date Title
Susse et al. Enantioselective formation of quaternary centers by allylic alkylation with first-row transition-metal catalysts
CN109529940B (zh) 二苯胺-膦-噁唑啉配体、其合成方法及其金属配合物和用途
Jiang et al. Highly enantioselective hydrogenation of simple ketones catalyzed by a Rh–PennPhos complex
Abdur‐Rashid et al. Synthesis of ruthenium hydride complexes containing beta‐aminophosphine ligands derived from amino acids and their use in the H2‐hydrogenation of ketones and imines
WO2012065571A1 (zh) 手性螺环吡啶胺基膦配体化合物与合成方法及其应用
Murtinho et al. Enantioselective ethylation of aldehydes with 1, 3-N-donor ligands derived from (+)-camphoric acid
Wang et al. A highly efficient kinetic resolution of Morita–Baylis–Hillman adducts achieved by N–Ar axially chiral Pd-complexes catalyzed asymmetric allylation
Saha et al. Selective hydrogenation of nitriles to secondary amines catalyzed by a pyridyl-functionalized and alkenyl-tethered NHC–Ru (II) complex
CN107866282A (zh) 一类含氮膦配体在烯烃氢甲酰化串联反应中的应用
Zeng et al. Synthesis and characterization of novel chiral bidentate P, N-containing ligands and ruthenium (II) complex. The application in asymmetric transfer hydrogenation of ketones
RU2446154C2 (ru) Сульфонилированные дифенилэтилендиамины, способ их получения и применение в катализе гидрирования с переносом водорода
CN105859783A (zh) 一种新型手性膦配体以及包含该配体的金属催化剂、其制备方法与应用
CN109574946B (zh) 二苯胺-胺-噁唑啉配体、合成方法及其金属配合物和用途
CA2598383C (en) Method for asymmetric hydrosilylation of ketones
CN109593085B (zh) 吡啶-酰胺-噁唑啉配体、其合成方法及其金属配合物和用途
Maj et al. Asymmetric hydrogenation of 2, 3-dihydro-1H-inden-1-one oxime and derivatives
CN111848322B (zh) 一种轴手性氧化吲哚取代的苯乙烯类化合物及其拆分方法与应用
CN113880822B (zh) 一种手性含亚胺喹啉噁唑啉类化合物及其金属络合物以及制备方法和应用
Xu et al. Asymmetric addition of phenylacetylene to aldehydes catalyzed by β‐sulfonamide alcohol‐titanium complex
CN109666049B (zh) 手性氨基磺酰胺配体金属络合物及其在催化反应中的应用
CN114031477B (zh) 一种钴催化酰胺类化合物还原成胺类化合物的方法
Meriç et al. New functional chiral P-based ligands and application in ruthenium-catalyzed enantioselective transfer hydrogenation of ketones
Li et al. Synthesis of new β-hydroxy amide ligands and their Ti (IV) complex-catalyzed enantioselective alkynylation of aliphatic and vinyl aldehydes
JP2015172024A (ja) 水素結合形成アミド基を持つキラル二環式ジエン配位子
Gu et al. Indan-f-amphox: An Efficient PNN Ligand for Iridium-Catalyzed Asymmetric Hydrogenation of β-Aryl β-Ketoesters

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant